hyoscine and dexamethasone on cervical preparation

Investigating the effect of injectable hyoscine and dexamethasone on cervical preparation in primiparous women with term pregnancy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240222061084N1

Enrollment

150

Registered

2024-03-23

Start date

2023-04-21

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical ripening. Maternal care for other conditions predominantly related to pregnancy

Interventions

Intervention 1: Intervention group: In the first group, the amount of 8 mg (equivalent to 2 cc) of dexamethasone (manufactured by Iran Hormon Company/Iran) intravenously. Intervention 2: Intervention

Eligibility

Sex/Gender

Female

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Primiparous Singelton Term pregnancy

Exclusion criteria

Exclusion criteria: History of infertility Cord prolapse Placenta decollement

Design outcomes

Primary

Measure	Time frame
Duration of first and second labor phase. Timepoint: During Labor. Method of measurement: by the concerned resident with physical examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaba Najafi

Shahre-kord University of Medical Sciences

njfi.saba@gmail.com+98 38 3333 0061

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026